Archives: Agenda

• Designing an adaptable supply chain to remain agile in the face of disruptions
• Leveraging technologies to improve your visibility and end to end supply chain
• Incorporating risk assessment and building contingency protocols early to be more prepared
• Learning on the go and acting fast as new challenges appear

• General explanation of the challenge : agility / perf
• Transfo in progress regarding digitalization
• Focus on AI current transformation and hopes

Cell and Gene Therapy logistics are at the forefront of innovation in clinical trial services. With highly sensitive materials and strict timelines, every step of the supply chain must be meticulously managed from start to finish. In this session, we will look at the logistical challenges whilst delivering practical insights into navigating logistical complexities.

• Overview of the Cell and Gene Therapy Landscape

• Logistical Challenges

• What to look for in a reliable logistics partner

• Overcoming regulatory and compliance hurdles
• Ensuring packaging and labelling meets country specific requirements
• Considering solutions for temperature control management during shipping
• Coordinating between depots, CROs, carriers and sites

• Sharing industry benchmarking outcomes
• Considering synergy opportunities
• Highlighting key challenges for the next 5 years

• What are AI Teammates, and why do they matter?
• How teammates elevate risk management with proactive detection and smart alerts

Drug development is advancing in a period shaped by regulatory change, geopolitical pressure, and increasing operational complexity. For biotech organizations running global and adaptive trials, maintaining clinical supply continuity has become essential to sustaining momentum and reducing risk.

In this presentation, we examine how confidence in clinical supply is built through readiness, scale, and operational foresight. Drawing on real-world experience across regions and modalities, the session explores how stable infrastructure and adaptable execution help keep trials moving with greater predictability as conditions evolve.

Specifically, this presentation will share:

• How end-to-end clinical supply control and a globally distributed network support continuity across complex trial designs and geographies
• Practical approaches to managing trade, tariff, and compliance risk through proactive planning and regional operating models
• How applied AI and automation in clinical supply operations are improving quality, efficiency, and reliability while maintaining regulatory control